Prevention and Treatment

As obesity and lipodystrophy have increased among aging adults living with HIV, so have related conditions including sarcopenia, diabetes, renal and cardiovascular diseases. Building on the previous webinars, this final session focuses on the evidence-based pharmacological and non-pharmacological strategies to prevent and treat these clinical conditions in PLHIV.

Prevention and Treatment of the Clinical Conditions Associated with Obesity and Lipodystrophy
View the webinar

Amanda Willig, PhD, RD
University of Alabama, Birmingham

Gina Dobbs, NP, RN
University of Alabama, Birmingham

The objectives of this webinar are:

• Review pharmacological and surgical strategies for managing clinical conditions associated with excess abdominal fat and lipodystrophy in PLHIV
• Review non-pharmacological strategies for managing clinical conditions associated with excess abdominal fat and lipodystrophy in PLHIV
• Describe implications of these therapies for special populations (e.g., women, older adults)
• Illustrate how to integrate these strategies into routine HIV care in various clinic settings

Recommended reading
Van der Kolk, B. A. (2015). The body keeps the score: Brain, mind, and body in the healing of trauma. Penguin Books.

After watching the entire webinar and successful completing the evaluation, you receive 1.0 CNE or a Certificate of Participation. The link for the evaluation will be posted at the end.

Additional Resources

Healthy Living

• American Heart Association- Healthy for Good
• American Heart Association’s Diet and Lifestyle Recommendations

Exercise

• American College of Sports Medicine- Fit Society Page
• Exercise is Medicine for Health Care Providers
• Physical Activity Guidelines

Nutrition

• Academy of Nutrition and Dietetics
• Nutrition.gov
• The Nutrition Source
• Dietary Guidelines

References

• Eckel, R.H., Jakicic, J.M., Ard, J.D., Hubbard, V.S., de Jesus, J.M., Lee, I.M., Lichtenstein, A.H., Loria, C.M., Millen, B.E., Miller, N.H. and Nonas, C.A., 2013. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk. Circulation, pp.01-cir.
• Falutz, Julian, et al. "Metabolic effects of a growth hormone–releasing factor in patients with HIV." New England Journal of Medicine 357.23 (2007): 2359-2370.
• Hirshkowitz, M., Whiton, K., Albert, S.M., Alessi, C., Bruni, O., DonCarlos, L., Hazen, N., Herman, J., Katz, E.S., Kheirandish-Gozal, L. and Neubauer, D.N., 2015. National Sleep Foundation’s sleep time duration recommendations: methodology and results summary. Sleep Health, 1(1), pp.40-43.
• Lake, Jordan E., et al. "Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection." Clinical Infectious Diseases 64.10 (2017): 1422-1429.
• Mussi, C., 2016. Nutrition and physical exercise in older patients with HIV. In Managing the Older Adult Patient with HIV (pp. 189-205). Springer International Publishing.
• O’Brien, K.K., Tynan, A.M., Nixon, S.A. and Glazier, R.H., 2016. Effectiveness of aerobic exercise for adults living with HIV: systematic review and meta-analysis using the Cochrane Collaboration protocol. BMC infectious diseases, 16(1), p.182
• O’Brien, K.K., Tynan, A.M., Nixon, S.A. and Glazier, R.H., 2017. Effectiveness of Progressive Resistive Exercise (PRE) in the context of HIV: systematic review and meta-analysis using the Cochrane Collaboration protocol. BMC infectious diseases, 17(1), p.268.